Integrated delivery device for continuous glucose sensor

  • US 8,920,401 B2
  • Filed: 04/30/2012
  • Issued: 12/30/2014
  • Est. Priority Date: 02/26/2004
  • Status: Active Grant
First Claim
Patent Images

1. An integrated diabetes management system for selectively switching between automated and fail-safe modes, the system comprising:

  • a glucose sensor, wherein the glucose sensor is configured to substantially continuously measure glucose concentration in a host for a period exceeding one hour, and to output a data stream, including one or more sensor data points; and

    a processor module operably connected to the glucose sensor, wherein the processor module is configured to receive the data stream, to calculate a therapy comprising instructions for administration of a medicament, and to send the instructions to a medicament delivery device, wherein the processor module is configured to operate the integrated system in an automated mode unless a fail-safe mode is triggered, wherein the automated mode does not require user interaction to send the instructions to the medicament delivery device, wherein in the fail-safe mode, the processor module is configured to prompt the host for input before sending the instructions to the medicament delivery device, and wherein the fail-safe mode is automatically triggered responsive to a predetermined fail-safe condition.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×